Annalisa Gessani

Rapamycin treatment for amyotrophic lateral sclerosis

Jessica Mandrioli, Roberto D’Amico, Elisabetta Zucchi et al. · Medicine · 2018 · 126 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)

Jessica Mandrioli, V. Crippa, Cristina Cereda et al. · BMJ Open · 2019 · 66 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease

Francesco Cavallieri, Carla Budriesi, Annalisa Gessani et al. · Frontiers in Neurology · 2021 · 32 citations · Full text

Health Professions, Neurology, Neuroscience +16

High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial

Elisabetta Zucchi, Marco Vinceti, Carlotta Malagoli et al. · Annals of Clinical and Translational Neurology · 2019 · 27 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +17

Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy

Giulia Gianferrari, Ilaria Martinelli, Elisabetta Zucchi et al. · Biomedicines · 2022 · 24 citations · Full text

Life Sciences, Genetics, Neurology +17